Limited shock wave therapy vs sham treatment in men with Peyronie's disease: Results of a prospective randomized controlled double-blind trial

BJU International

Volumn 106, Issue 9, 2010, Pages 1352-1356

  Chitale, Sudhanshu ^a   Morsey, Mohammed ^a   Swift, Louise ^b   Sethia, Krishna ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Peyronie's disease; randomized controlled trial; shock wave therapy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; EXTRACORPOREAL LITHOTRIPSY; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MALE; PENIS; PEYRONIE DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SHAM PROCEDURE; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADULT; AGED; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; PENILE ERECTION; PENILE INDURATION; QUALITY OF LIFE; TREATMENT OUTCOME; ULTRASONIC THERAPY;

EID: 78349283098     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09331.x     Document Type: Article

References (22)

1. Lebret T, Loison G, Herve J-M, et al. Extracorporeal shock wave therapy in the treatment of Peyronie's disease. Experience with a standard lithotripter (Siemens-Multiline). Urology 2002; 59: 657-61
2. Butz M, Teichert HM,. Treatment of Peyronie's disease by extracorporeal shock waves. J Urol 1998; 159 (Suppl.): 118 (Abstract 457)
3. Colombo F, Mantovani F, Pateli E,. Shock wave therapy in la Peyronie's disease: two year's experience. Eur Urol 1999; 35 (Suppl. 2): 124 (Abstract)
4. Gianneo E, Nespoli R, Conti G,. La Peyronie's disease and extracorporeal shock wave therapy: our experience. J Urol 1999; 161 (Suppl.): 205 (Abstract 786)
5. Manikandan R, Islam W, Srinivasan V, Evans CM,. Evaluation of extracorporeal shock wave therapy in Peyronie's disease. Urology 2002; 60: 795-9
6. Hauck EW, Altinkilic BM, Ludwig M, et al. Extracorporeal shock wave therapy in the treatment of Peyronie's disease. Eur Urol 2000; 38: 663-70
7. Gholami SS, Lue TF,. Peyronie's disease. Urol Clin North Am 2001; 28: 377-90
8. Williams JL, Thomas GG,. The natural history of Peyronie's disease. J Urol 1970; 103: 75-6
9. Gelbard MK, Dorey F, James K,. The natural history of Peyronie's disease. J Urol 1990; 144: 1376-9
10. Nelson CJ, DiBlasio CJ, Kendirci M, Hellstrom WJG, Mulhall JP,. The chronology of depression and distress in men with Peyronie's disease. J Urol 2007; 177 (Suppl.): 253; Abstract
11. Husain J, Lynn NN, Jones DK, Collins GN, O'Reilly PH,. Extracorporeal shock wave therapy in the management of Peyronie's disease: initial experience. BJU Int 2000; 86: 466-8
12. Kiyota H, Ohishi Y, Asano K, et al. Extracorporeal shock wave treatment for Peyronie's disease using EDAP LT 02; preliminary results. Int J Urol 2002; 9: 110-3
13. Seftel A,. Extracorporeal shock wave therapy in the treatment of Peyronie's disease: experience with standard lithotripter (Siemens Multiline). J Urol 2002; 168: 2322
14. Mirone V, Imbimbo C, Palmieri A, Fusco F,. Our experience on the association of a new physical and medical therapy in patients suffering from induratio penis plastica. Eur Urol 1999; 36: 327-30
15. Abdel-Salam Y, Budair Z, Renner C, et al. Treatment of Peyronie's disease by extracorporeal shock wave therapy: evaluation of our preliminary results. J Endourol 1999; 13: 549-52
16. Hatzichristodoulou G, Meisner C, Stenzi A, Lahme S,. Efficacy of extracorporeal shock wave therapy on plaque size and sexual function in patients with Peyronie's disease-Results of a prospective, randomized, placebo-controlled study. J Urol 2007; 177 (Suppl.): 251. Abstract 747
17. Hatzichristodoulou G, Meisner C, Liske P, Stenzl A, Lahme S,. Efficacy of extracorporeal shock wave therapy (ESWT) in patients with Peyronie's disease (PD)-First results of a prospective, randomized, placebo-controlled, single-blind study. J Urol 2006; 175 (Suppl.): 320. Abstract
18. Taylor J, Forster JA, Browning AJ, Biyani CS,. Extracorporeal shockwave therapy for Peyronie's disease. Who benefits? J Endourol 2006; 20: 135-8
19. Mirone V, Palmieri A, Granata AM, Piscopo A, Verze P, Ranavolo R,. Ultrasound-guided ESWT in Peyronie's disease plaques. Arch Ital Urol Androl 2000; 72: 384-7
20. Baumann M, Bohme H, Tauber R,. Extracorporal shock wave therapy (ESWT) in combination with local verapamil injections in the treatment of IPP (induratio penis plastica). Aktuel Urol 2001; 32: 61-4
21. Claro JA, Passerotti CC, Figueiredo Neto AC, Nardozza JRA, Ortiz V, Srougi M,. An alternative non-invasive treatment for Peyronie's disease. Int Braz J Urol 2004; 30: 199-204
22. Sommer F, Schwarzer U, Wassmer G, et al. Epidemiology of Peyronie's disease. Int J Impotence Res 2002; 14: 379-83